News

Q2 2025 Earnings Call Transcript August 1, 2025 Silvercrest Asset Management Group Inc. reports earnings inline with ...
Reported net income attributable to Class A shareholders was $1.9 million or $0.21 per basic and diluted share. Adjusted EBITDA was $5.7 million, or 18.7% of revenue. Adjusted net income was $3.3 ...
Designed to reduce the risk of graft-related infection from MRSA, P.aeruginosa, and S.epidermidis, INTERGARD SILVER is the first antimicrobial graft on the market. The safety and benefits of ...